Fee-Way Pharmaceuticals Private Limited
About Fee-Way Pharmaceuticals Private Limited
Data last updated:
Fee-Way Pharmaceuticals Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2021PTC155278.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Kumar Sharma and Rohit Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Faryad S/O Mohd Firaset Chetna Colony Nakatiya, Bareilly, Uttar Pradesh, India – 243123.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.87 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹14,089 (net margin -4.9%) and EBITDA of -₹13,440 (EBITDA margin -4.7%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Faryad S/O Mohd Firaset Chetna Colony Nakatiya, Bareilly, Uttar Pradesh, India – 243123
- IndustryChemicals, Manufacturing, Other Chemical Product, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Fee-Way Pharmaceuticals Private Limited
The main business activity of Fee-Way Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Fee-Way Pharmaceuticals Private Limited FY 2024 filings available
Fee-Way Pharmaceuticals Private Limited reported revenue of ₹2.87 Lakh (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Fee-Way Pharmaceuticals Private Limited
Revenue fell 8% in the latest year. EBITDA rose 79% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Fee-Way Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹13,440 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹14,089 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Fee-Way Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -4.7% | •••• | •••• |
| Net Profit Margin | -4.9% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Fee-Way Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Fee-Way Pharmaceuticals Private Limited
Fee-Way Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Its own revenue is ₹2.87 Lakh.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Niren Drugs and Pharmaceuticals Pvt Ltd | ₹2.91 Lakh | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| BGR Pharmaceuticals Private Limited | ₹2.91 Lakh | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| Prescrizione Pharmaceuticals Private Limited | ₹2.88 Lakh | •••• | •••• | •••• | - | Chennai City Corporation, Tamil Nadu, India |
| Vive Pharmaceuticals Private Limited | ₹2.87 Lakh | •••• | •••• | •••• | - | Ameerpet, Telangana, India |
| Medonic Pharmaceuticals Private Limited | ₹2.87 Lakh | •••• | •••• | •••• | - | Delhi, India |
| Fee-Way Pharmaceuticals Private Limited this company | ₹2.87 Lakh | •••• | •••• | •••• | - | Bareilly, Uttar Pradesh, India |
| Aimcare Pharmaceuticals Private Limited | ₹2.86 Lakh | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Morp Mediz Pharmaceuticals Private Limited | ₹2.86 Lakh | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Finetec Pharmaceuticals Private Limited | ₹2.85 Lakh | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Alkvin Pharmaceuticals Private Limited | ₹2.85 Lakh | •••• | •••• | •••• | - | Darbhanga, Bihar, India |
| Payama Pharmaceuticals Private Limited | ₹2.84 Lakh | •••• | •••• | •••• | - | Dadri, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Fee-Way Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and growth of each peer are in the company report.
Board of Directors of Fee-Way Pharmaceuticals Private Limited
Fee-Way Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kumar Sharma | Director | 09 Nov 2023 | 2 Years 10 Months | Current |
| Rohit Sharma | Director | 11 Nov 2021 | 4 Years 10 Months | Current |
Charges & Borrowings of Fee-Way Pharmaceuticals Private Limited
Fee-Way Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Fee-Way Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Fee-Way Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fee-Way Pharmaceuticals Private Limited
Fee-Way Pharmaceuticals Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Mohd Irfan Ansari ceased to be Director on 09 Nov 2023.
Credit Ratings, Litigation & Regulatory Alerts for Fee-Way Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fee-Way Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fee-Way Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fee-Way Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fee-Way Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fee-Way Pharmaceuticals Private Limited
Fee-Way Pharmaceuticals is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 November 2021 (5+ years old) and is registered under CIN U24299UP2021PTC155278.
Fee-Way Pharmaceuticals reported revenue of ₹2.87 Lakh for FY 2024 (down 8% YoY).
Fee-Way Pharmaceuticals has 2 current directors:
- Rajeev Kumar Sharma - Director
- Rohit Sharma - Director
Fee-Way Pharmaceuticals reported a net loss of ₹14,089 (net margin -4.9%) and EBITDA of -₹13,440 (EBITDA margin -4.7%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Fee-Way Pharmaceuticals is U24299UP2021PTC155278. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fee-Way Pharmaceuticals was incorporated on 11 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Fee-Way Pharmaceuticals by revenue are Niren Drugs and Pharmaceuticals Pvt Ltd, BGR Pharmaceuticals Private Limited, Prescrizione Pharmaceuticals Private Limited, Vive Pharmaceuticals Private Limited, Medonic Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Mohd Irfan Ansari ceased to be Director on 09 Nov 2023. Mohd Shoaib ceased to be Director on 09 Nov 2023. Rajeev Kumar Sharma was appointed as Director on 09 Nov 2023. Fee-Way Pharmaceuticals has 4 board changes on record in total.
The registered office of Fee-Way Pharmaceuticals is at CO Faryad SO Mohd Firaset Chetna Colony Nakatiya, Bareilly, Uttar Pradesh, India – 243123.
Fee-Way Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Fee-Way Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.